Today in Business
SEE OTHER BRANDS

Your business news from the world

Today in Business: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Business.

Press releases published on May 31, 2025

Libtayo® (cemiplimab) Phase 3 Data in the Adjuvant Treatment of Post-Surgical High-Risk Cutaneous Squamous Cell Carcinoma (CSCC) Have Potential to Be Practice-Changing

Libtayo® (cemiplimab) Phase 3 Data in the Adjuvant Treatment of Post-Surgical High-Risk Cutaneous Squamous Cell Carcinoma (CSCC) Have Potential to Be Practice-Changing

Libtayo demonstrated a 68% reduction in the risk of disease recurrence or death, the primary endpoint of the trial (p<0.0001) Libtayo also demonstrated 80% and 65% reductions in the risk of locoregional and distant recurrence, respectively, compared to …

Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer

Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer

Pivotal Phase 3 VERITAC-2 clinical trial results presented at ASCO demonstrate 2.9-month improvement in median progression-free survival when compared to fulvestrant in second line-plus patients with an estrogen receptor 1 mutation Vepdegestrant was …

leagend Debuts Smart UPS Battery Management Solution to Strengthen Power Security for Financial Institutions

leagend Debuts Smart UPS Battery Management Solution to Strengthen Power Security for Financial Institutions

leagend SOLUTIONS, a global leader in battery monitoring and intelligent power management systems, has officially launched its UPS Battery Management Solution. SHENZHEN, GUANGDONG, CHINA, May 31, 2025 /⁨EINPresswire.com⁩/ -- In response to the growing …

Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde® regimen in metastatic pancreatic adenocarcinoma

Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde® regimen in metastatic pancreatic adenocarcinoma

Phase III NAPOLI 3 trial is the largest and has the longest follow-up for an interventional study in metastatic pancreatic adenocarcinoma1 Post-hoc analysis of NAPOLI 3 study determined characteristics associated with long-term survival, with median …

Une analyse « Late Breaking » démontre les caractéristiques associées à la survie globale à long terme des patients avec un adénocarcinome pancréatique métastatique traités par Onivyde®

Une analyse « Late Breaking » démontre les caractéristiques associées à la survie globale à long terme des patients avec un adénocarcinome pancréatique métastatique traités par Onivyde®

L’essai de Phase III NAPOLI 3 est la plus grande étude interventionnelle réalisée à ce jour avec la plus longue période de suivi des patients avec un adénocarcinome pancréatique métastatique1. L’analyse post-hoc de l’étude NAPOLI 3 a permis de déterminer …

Immatics IMA203 PRAME Cell Therapy Data Presented at  2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma

Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma

Extended Phase 1b trial follow-up on IMA203 PRAME cell therapy in 33 heavily pretreated patients with metastatic melanoma demonstrates favorable tolerability and promising clinical activity with ongoing deep and durable objective responses up to >2.5 years …

Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer

Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer

26% preliminary objective response rate observed in heavily pre-treated patients with metastatic microsatellite stable colorectal cancer (MSS CRC) without liver metastases Deep and durable responses ongoing for up to 37 weeks through the data cutoff, …

Maryland Student Wins NFTE Capital Youth Entrepreneurship Challenge

Maryland Student Wins NFTE Capital Youth Entrepreneurship Challenge

Washington, DC, May 31, 2025 (GLOBE NEWSWIRE) -- Global entrepreneurship education nonprofit Network for Teaching Entrepreneurship (NFTE) has named four local student businesses as the winners of its annual Capital Regional Youth Entrepreneurship Challenge …

OGN CLASS NOTICE: Organon & Co. Investors may have been Affected by Fraud – Contact BFA Law before July 22 Court Deadline (NYSE:OGN)

OGN CLASS NOTICE: Organon & Co. Investors may have been Affected by Fraud – Contact BFA Law before July 22 Court Deadline (NYSE:OGN)

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

IOVA CLASS NOTICE: Iovance Biotherapeutics, Inc. Investors may have been Affected by Fraud – Contact BFA Law before July 14 Court Deadline (NASDAQ:IOVA)

IOVA CLASS NOTICE: Iovance Biotherapeutics, Inc. Investors may have been Affected by Fraud – Contact BFA Law before July 14 Court Deadline (NASDAQ:IOVA)

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

CODI CLASS NOTICE: Compass Diversified Holdings Investors may have been Affected by Fraud – Contact BFA Law before July 8 Court Deadline (NYSE:CODI)

CODI CLASS NOTICE: Compass Diversified Holdings Investors may have been Affected by Fraud – Contact BFA Law before July 8 Court Deadline (NYSE:CODI)

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

VTRS CLASS NOTICE: Viatris Inc. Investors may have been Affected by Fraud – Contact BFA Law before June 3 Court Deadline (NASDAQ:VTRS)

VTRS CLASS NOTICE: Viatris Inc. Investors may have been Affected by Fraud – Contact BFA Law before June 3 Court Deadline (NASDAQ:VTRS)

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

CIVI CLASS NOTICE: Civitas Resources, Inc. Investors may have been Affected by Fraud – Contact BFA Law before July 1 Court Deadline (NYSE:CIVI)

CIVI CLASS NOTICE: Civitas Resources, Inc. Investors may have been Affected by Fraud – Contact BFA Law before July 1 Court Deadline (NYSE:CIVI)

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

BBAI CLASS NOTICE: BigBear.ai Holdings, Inc. Investors may have been Affected by Fraud – Contact BFA Law before June 10 Court Deadline (NYSE:BBAI)

BBAI CLASS NOTICE: BigBear.ai Holdings, Inc. Investors may have been Affected by Fraud – Contact BFA Law before June 10 Court Deadline (NYSE:BBAI)

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

RDDT INVESTIGATION NOTICE: Reddit, Inc. is being Investigated for Securities Fraud – Contact BFA Law if You Suffered Losses (NYSE:RDDT)

RDDT INVESTIGATION NOTICE: Reddit, Inc. is being Investigated for Securities Fraud – Contact BFA Law if You Suffered Losses (NYSE:RDDT)

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

URGN CLASS ACTION NOTICE: UroGen Pharma Ltd. has been Sued for Securities Fraud after Stock Plummets 45% – Contact BFA Law if You Suffered Losses (NASDAQ:URGN)

URGN CLASS ACTION NOTICE: UroGen Pharma Ltd. has been Sued for Securities Fraud after Stock Plummets 45% – Contact BFA Law if You Suffered Losses (NASDAQ:URGN)

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

ELV CLASS NOTICE: Elevance Health, Inc. Investors may have been Affected by Fraud – Contact BFA Law before July 11 Court Deadline (NYSE:ELV)

ELV CLASS NOTICE: Elevance Health, Inc. Investors may have been Affected by Fraud – Contact BFA Law before July 11 Court Deadline (NYSE:ELV)

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

Investors Mobilize to ‘Free Linqto’ Amid Concerns of Mismanagement

Investors Mobilize to ‘Free Linqto’ Amid Concerns of Mismanagement

LAS VEGAS, May 31, 2025 (GLOBE NEWSWIRE) -- Concerned customers of the investment platform Linqto have joined together to demand answers from the tech company’s new management, which has suspended operations and frozen users’ accounts since February of …

The International Golf Tournament "Vietnam Legends Championship 2025" Officially Launches

The International Golf Tournament "Vietnam Legends Championship 2025" Officially Launches

HO CHI MINH CITY, Vietnam, May 31, 2025 (GLOBE NEWSWIRE) -- Under the direction of the People’s Committee of Ho Chi Minh City, the Department of Culture and Sports of Ho Chi Minh City — acting as the Head of the Organizing Committee — in coordination with …

Reconnaissance des malades liés aux pesticides : Victoire pour le cas de Serge Boily

Reconnaissance des malades liés aux pesticides : Victoire pour le cas de Serge Boily

MONTRÉAL, 31 mai 2025 (GLOBE NEWSWIRE) -- Victimes des pesticides du Québec1 (VPQ) est fière d’annoncer aujourd’hui la reconnaissance finale de la maladie de Parkinson comme maladie professionnelle pour Serge Boily, président de Victimes des pesticides du …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service